Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

A new king of quantitation?

13 Nov 2019
General interest

Who will come out on top over four rounds of action? Including:

  • Method development
  • Maintenance
  • Sample analysis
  • Data management

Click here for a more in depth comparison

Click here to find out more about Drug Development Solutions Ltd


HRMS in DMPK banner

Top content

  • Novel liquid biopsy test enhances early cancer detection with high accuracy
  • Major M&A deals impacting bioanalysis in 2025

Related tags

analysis HRMS LGC quantitation Triple quadrupole
Previous article Next article

Related articles

6 JUN 2012 COLLABORATIONS AND MERGERS
Conference Report: Bioanalytical sessions at the 2011 Eastern Analytical Symposium
22 NOV 2018 IMMUNOGENICITY
Regulation and standardisation of immunogenicity assessments: a CRO’s perspective
14 JUL 2016 GENERAL INTEREST
Quantitative HRMS
5 MAR 2015 MS (LC–MS/MS, HRMS, IMS)
Webinar Q&A follow-up: ‘Protein quantitation with confidence’
19 AUG 2019 JOURNAL ARTICLES
Microflow UPLC and high-resolution MS as a sensitive and robust platform for quantitation of intact peptide hormones
15 AUG 2016 GENERAL INTEREST
Quantitation by High Resolution Mass Spectrometry: Case Study of TOF MS for the Quantitation of Allopurinol from Human Plasma (SCIEX)
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone